A Study of LY3090106 in Japanese and Caucasian Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The main purpose of this study is to evaluate the safety of a study drug known as LY3090106 in healthy Caucasian and Japanese participants. Side effects and tolerability will be documented. Blood samples will be taken to compare how the body handles the drug. The study will last about 12 weeks, not including screening or additional follow‐up.
Epistemonikos ID: a7db48d9e3cc5bd2bf85680a9505dea58cdcf511
First added on: May 21, 2024